Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Male or female ≥ 10 years of age
Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
None
University of California, San Francisco
Lead sponsor
UCB Pharma
Collaborator